Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00451698 · ClinicalTrials.gov registry record · NA
Erythropoietin and Pediatric Cardiac Surgery
A NA study, sponsored by Medical College of Wisconsin.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT00451698 is a NA study that was terminated before completion, run by Medical College of Wisconsin. The registered enrollment target is 9 participants.
The verdict
NCT00451698, a NA study, was terminated before completion, sponsored by Medical College of Wisconsin.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Lack of bloodflow to the heart and brain when the heart is stopped during heart surgery can cause damage to those organs. We hypothesize that a single dose of erythropoietin prior to the heart bypass portion of surgery may protect the infant human heart and brain from injury. This randomized clinical trial will involve 120 children, age 6 weeks to 18 years, requiring heart bypass surgery for congenital heart defects.
Interventions
- DRUG acyanotic erythropoietin
- DRUG acyanotic placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00451698
The ClinicalTrials.gov registry entry for NCT00451698 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which acyanotic erythropoietin is the first listed.
NCT00451698 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00451698 about?
NCT00451698 is a clinical study titled "Erythropoietin and Pediatric Cardiac Surgery". Lack of bloodflow to the heart and brain when the heart is stopped during heart surgery can cause damage to those organs. We hypothesize that a single dose of erythropoietin prior to the heart bypass portion of surgery may protect the infant human heart and brain from injury. This randomized clinic...
What is the current status of trial NCT00451698?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2007-10. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00451698?
The interventions under investigation include: acyanotic erythropoietin (DRUG), acyanotic placebo (DRUG).
Who is sponsoring clinical trial NCT00451698?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.